Treatment of chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists

5-hydroxytryptamine 3 (5-HT3) receptor antagonists have proved to be highly efficacious in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). However, several questions remain concerning the relative efficacy of various approved anti-emetics, especially with respect to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Deutsche medizinische Wochenschrift 2006-12, Vol.131 (48), p.2707
Hauptverfasser:	Abenhardt, W, Bosse, D, Böning, L, Bojko, P, Hitz, H, Völkl, S, Fromm, M, Mittermüller, J, Göldel, N, Schick, H-D, Dietzfelbinger, H, Hinke, A
Format:	Artikel
Sprache:	ger
Schlagworte:	Antineoplastic Agents - adverse effects Humans Nausea - chemically induced Nausea - prevention & control Neoplasms - drug therapy Serotonin 5-HT3 Receptor Antagonists Vomiting - chemically induced Vomiting - prevention & control
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!